Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek, announces a collaboration with GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. This collaboration will enable large-scale, artificial intelligence (AI) driven medical imaging migrations by utilizing standardized, high-quality imaging data essential for Enterprise Imaging solutions. By streamlining application migration, healthcare providers worldwide can adopt advances in diagnostic and care decision capabilities more efficiently.
As a key collaborator in GE HealthCare's Software as a Service (SaaS) and cloud transformation initiatives, Enlitic will support GE's healthcare clients in ensuring faster access to patient related imaging data across their delivery networks helping to improve operational efficiency and faster informed care decisions.
Why This Collaboration Matters
Next-Generation AI and Automation: Laitek's industry-leading data migration technology will accelerate the transition of customers to GE HealthCare's newest Enterprise Imaging and PACS solutions such as Datalogue™ and True PACS, ensuring minimal disruption and faster time-to-value.
Enterprise-Scale Migration: The collaboration will provide a scalable, secure, and high-performance cloud migration framework for GE HealthCare customers, handling vast amounts of imaging data more efficiently and minimizing disruption and ensuring high quality of data.
Standardization and Compliance: Enlitic's platform ensures seamless standardization, adhering to global regulations and ensuring interoperability across different imaging platforms.
Advanced Data Optimization: More than just moving data, AI-powered automation migrations tools can help clean, curate, and enhance imaging transitions, making it more accessible and actionable for clinical and research applications.
Reliability at Scale: Enlitic and Laitek (an Enlitic company) will leverage its proprietary high-performance migration engine, capable of processing large-scale imaging workloads while maintaining continuous clinical operations.
How This Will Work
Enlitic's Ensight Suite goes beyond traditional data migration by embedding AI automation and data intelligence into migrations tools for GE HealthCare's cloud and on-premise transitions. This collaboration aims to provide GE's healthcare clients with a seamless transition to the cloud while benefiting from improved data quality, accessibility, and efficiency.
The end-to-end migration process ensures that imaging data is carefully curated, structured, and optimized - empowering providers to meet their evolving analytic and workflow needs. By combining GE HealthCare's expertise in enterprise imaging with Enlitic's innovative AI and data transformation capabilities, this collaboration delivers a future where migrations provide an opportunity to upgrade customer's imaging data ecosystems.
Shared Vision for the Future of Healthcare Data
Michael Sistenich, CEO of Enlitic, shared his enthusiasm, stating, 'This is more than a collaboration - it is a shift in how healthcare institutions approach data. We are moving beyond conventional migrations, enabling healthcare providers to move to the cloud with confidence. By leveraging AI and automation, we will set a new standard in enterprise imaging that will ensure data is not only transferred but transformed into a strategic asset. Healthcare providers deserve solutions that do not just keep up but lead the way forward.'
Scott Miller, CEO of Solutions for Enterprise Imaging at GE HealthCare, said, 'Our collaboration with Enlitic is not just about efficiency—it is about revolutionizing how healthcare providers access, analyze, and act on their data. We are bridging the gap between legacy systems and the future of AI-powered healthcare, ensuring our customers are always ahead of the curve.'
As global healthcare organizations accelerate their digital transformation initiatives, this collaboration aims to ensure that imaging data migration is no longer a bottleneck, but rather, is a strategic enabler of cloud adoption. This collaboration demonstrates a shared commitment to innovation, intelligence, and impact. By uniting GE HealthCare's leadership in digital transformation with Enlitic's expertise in AI-driven automation and data refinement, the two companies are setting a new standard for healthcare data management.
About Enlitic
Enlitic delivers AI-powered solutions that revolutionize medical imaging data quality, optimize workflows, and empower healthcare organizations to extract real value from their data archives. With a focus on automation and interoperability, Enlitic ensures that data does not just move—it evolves.
For more information, visit enlitic.com and follow the company on LinkedIn and X.
About Laitek
Laitek is the industry leader in complex imaging data migrations, working directly with hospitals and serving as the trusted migration partner for PACS vendors worldwide.
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient's journey across the care pathway. Together our Imaging, Ultrasound and Image Guided Therapies, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.
David Wilson
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 hours ago
- Yahoo
Sonic Healthcare (ASX:SHL) shareholders have endured a 8.4% loss from investing in the stock three years ago
As an investor its worth striving to ensure your overall portfolio beats the market average. But in any portfolio, there are likely to be some stocks that fall short of that benchmark. We regret to report that long term Sonic Healthcare Limited (ASX:SHL) shareholders have had that experience, with the share price dropping 17% in three years, versus a market return of about 44%. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. During the three years that the share price fell, Sonic Healthcare's earnings per share (EPS) dropped by 28% each year. This fall in the EPS is worse than the 6% compound annual share price fall. This suggests that the market retains some optimism around long term earnings stability, despite past EPS declines. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free interactive report on Sonic Healthcare's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Sonic Healthcare, it has a TSR of -8.4% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments! Sonic Healthcare shareholders are up 10% for the year (even including dividends). Unfortunately this falls short of the market return. The silver lining is that the gain was actually better than the average annual return of 1.7% per year over five year. This suggests the company might be improving over time. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. For example, we've discovered 1 warning sign for Sonic Healthcare that you should be aware of before investing here. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
15 hours ago
- Yahoo
AGL Energy (ASX:AGL) investors are sitting on a loss of 20% if they invested five years ago
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in AGL Energy Limited (ASX:AGL), since the last five years saw the share price fall 39%. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Looking back five years, both AGL Energy's share price and EPS declined; the latter at a rate of 25% per year. This fall in the EPS is worse than the 9% compound annual share price fall. So the market may previously have expected a drop, or else it expects the situation will improve. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). This free interactive report on AGL Energy's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. As well as measuring the share price return, investors should also consider the total shareholder return (TSR). The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for AGL Energy the TSR over the last 5 years was -20%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! AGL Energy shareholders gained a total return of 8.9% during the year. But that return falls short of the market. But at least that's still a gain! Over five years the TSR has been a reduction of 4% per year, over five years. It could well be that the business is stabilizing. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - AGL Energy has 4 warning signs we think you should be aware of. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Australian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Business Wire
16 hours ago
- Business Wire
Securonix Acquires ThreatQuotient to Deliver Industry's Broadest and Deepest Threat Detection Investigation and Response
PLANO, Texas--(BUSINESS WIRE)--Today, Securonix, a five-time Leader in the Gartner® Magic Quadrant™ for Security Information and Event Management (SIEM), announced the acquisition of ThreatQuotient, a four-time leader in threat intelligence based on QKS Group Spark Matrix report and the force behind ThreatQ, the most innovative external threat intelligence platform. This combination will create a comprehensive, modular, and fully integrated AI-driven platform for threat detection, investigation, and response (TDIR), leveraging advanced analytics and insights across both internal and external threats. This acquisition accelerates the modernization of security operations by uniting internal and external threat intelligence with real-time analytics and agentic AI. Unlike external threat intelligence bolt-on solutions with disconnected management interfaces, the integrated platform from Securonix and ThreatQuotient will deliver unified visibility, faster response, and greater operational clarity. "Bringing threat intelligence management and SIEM together in a unified platform is a game changer. We've already seen the value of deeply enriched advanced analytics and detection in our Securonix SIEM environment—but coupling that with integrated threat curation, prioritization, and response should help customers move even faster. It means fewer swivel-chair investigations, more accurate triage, and greater confidence that security analysts are working with the most relevant threats. This kind of integration has the potential to accelerate the ability to detect, respond, and stay ahead," said Marcel Jonker, Director of Cybersecurity Operations at Cambia Health Systems. The integration of Securonix and ThreatQuotient promises to deliver up to a 70% reduction in Mean Time to Respond (MTTR), enabling security teams to detect, investigate, and remediate threats significantly faster. By combining curated threat intelligence with AI-driven automation, the solution will deliver exponential improvements in filtering out false positives, enriching alerts with actionable context, and automating historical threat sweeps and incident response. This reduces alert overload, speeds up root cause analysis, and minimizes manual handoffs—cutting investigation time from hours to minutes and enabling automated containment before threats escalate. 'Security teams are drowning in noise and struggling to keep up with evolving threats,' said Kash Shaikh, CEO and President of Securonix. 'This acquisition brings together Securonix's Agentic AI-driven Platform with ThreatQuotient's deep threat intelligence to deliver clarity, speed, and automated workflows to our customers, reducing false positives by up to 90%. Together, we're building the modern SOC Platform—proactive, intelligent, and built for what's next.' Kash added, 'Securonix and ThreatQuotient bring together complementary strengths—deep innovation across internal and external threat domains, and a shared commitment to innovation and customer service. Both companies serve enterprise and government customers as well as managed security service providers (MSSPs), and we're excited to welcome the talented ThreatQuotient team and their customers to Securonix.' Purpose-Built for Analysts. Proven Against Real-World Threats. ThreatQuotient's Threat Intelligence Platform (TIP) strength lies in delivering curated, contextualized threat intelligence that drives smart, timely decisions. When combined with Securonix's EON Agentic AI-based SIEM, SOAR, UEBA and Data Pipeline Manager, customers can accelerate their migration from reactive threat hunting-based defense to proactive, real-time, behavior-driven, open-agentic security operations. With this integration, Securonix customers and partners will enjoy the following benefits: Gain clear visibility: Integrate deep enriched real-time analytics from Securonix with curated external intelligence from ThreatQuotient to create a single, high-context stream of alerts. Eliminate blind spots and accelerate threat identification with confidence. Stay ahead of risk: Auto-enrich Indicator of compromise (IoCs) and preemptively respond to repeat attacks, blocking 90 percent before they start. Act smarter: Automate repetitive tasks, reduce false positives, and streamline investigations. Teams can stay focused on high-priority threats and reduce time spent on manual triage. Deploy your way: Continue to use ThreatQ as a standalone threat intelligence platform or as part of the fully integrated Securonix solution. Deploy on-premise or SaaS in a way that fits the current architecture and scales with needs. Accelerated Roadmap: Combined R&D synergies will accelerate upcoming roadmap innovations, including Agentic AI and ThreatQuotient's innovation priorities. With this acquisition, ThreatQuotient customers and partners will enjoy the following benefits: Increased Scale: ThreatQ customers can take advantage of Securonix's global R&D scale and GTM reach, including access to Securonix's Threat Labs Intelligence. Deeper Integrations: Gain access to an enriched roadmap and integration between Securonix's best-in-class SIEM, SOAR, and UEBA portfolio and ThreatQ, including extension of Agentic AI advancements. Continued Focus: Zero interruption of their existing service, as ThreatQuotient will continue to operate as a standalone offering, with no disruption to existing roadmap and workflows. 'Enterprises, government institutions and managed security service providers rely on ThreatQuotient to protect their mission critical businesses. Joining Securonix marks a powerful new chapter for ThreatQuotient. By uniting our strengths, we can accelerate innovation, expand our reach, and deliver greater value to our customers. I'm proud of what we've built and excited for what's ahead,' said John Czupak, CEO of ThreatQuotient. BTIG, LLC served as exclusive financial advisor, and King & Spalding LLP served as legal advisor to ThreatQuotient. Vinson & Elkins LLP served as legal advisor to Securonix. About Securonix Securonix is leading the transformation of cybersecurity with the industry's first Unified Defense SIEM powered by agentic AI, purpose-built to decide and act across the threat lifecycle with a human-in-the-loop philosophy. Built for scale, precision, and speed, our cloud-native platform empowers global enterprises to shift from reactive security to proactive, autonomous operations. Recognized as a Leader in the Gartner® Magic Quadrant™ for SIEM and a Customers' Choice by Gartner Peer Insights™, Securonix is driving the next era of intelligent, autonomous security operations. Learn more at About ThreatQuotient ThreatQuotient improves security operations by fusing disparate data sources, tools, and teams to accelerate threat detection, investigation, and response (TDIR). ThreatQ is the first purpose-built, data-driven threat intelligence platform that helps teams prioritize, automate, and collaborate on security incidents; enables more focused decision-making; and maximizes limited resources by integrating existing processes and technologies into a unified workspace. The result is reduced noise, clear priority threats, and the ability to automate processes with high-fidelity data. ThreatQuotient's leading integration marketplace, data management, orchestration, and automation capabilities support multiple use cases including threat intelligence management and sharing, incident response, threat hunting, spear phishing, alert triage, and vulnerability management. For more information, visit
